Skip to main content
Top
Published in: Medical Oncology 4/2014

01-04-2014 | Original Paper

Oncogenicity of the transcription factor SOX8 in hepatocellular carcinoma

Authors: Siquan Zhang, Cong Zhu, Limin Zhu, Huafeng Liu, Shourong Liu, Nianbo Zhao, Jing Wu, Xiaoxiao Huang, Yujuan Zhang, Jie Jin, Ting Ji, Xianfeng Ding

Published in: Medical Oncology | Issue 4/2014

Login to get access

Abstract

SOX genes play an important role in a number of developmental processes. SOXs have been demonstrated to have potential roles as either tumor suppressors or promoters in various neoplastic tissues depending on the tumor status and type. The aim of this study was to investigate the functional role of SOXs in human cancers. Gene expression changes of SOXs in human hepatocellular carcinoma (HCC) tissues were detected using real-time quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) analysis and immunohistochemistry and compared with those in non-cancerous hepatic tissues. We found by qRT-PCR analysis and immunohistochemistry that the gene SOX8 was significantly upregulated in HCC. Furthermore, we discovered that SOX8 promoted cancer cell proliferation in vitro and that its expression was correlated with elevated β-catenin levels in HCC, whose function was required for the oncogenic effects of SOX8.
Literature
1.
go back to reference Tanaka S, Arii S. Molecular targeted therapies in hepatocellular carcinoma. Semin Oncol. 2012;39(4):486–92.PubMedCrossRef Tanaka S, Arii S. Molecular targeted therapies in hepatocellular carcinoma. Semin Oncol. 2012;39(4):486–92.PubMedCrossRef
2.
go back to reference Vinas A, et al. Mapping of DNA sex-specific markers and genes related to sex differentiation in turbot (Scophthalmus maximus). Mar Biotechnol (NY). 2012;14(5):655–63.CrossRef Vinas A, et al. Mapping of DNA sex-specific markers and genes related to sex differentiation in turbot (Scophthalmus maximus). Mar Biotechnol (NY). 2012;14(5):655–63.CrossRef
4.
go back to reference Coco C, et al. Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients. J Exp Clin Cancer Res. 2012;31:71.PubMedCentralPubMedCrossRef Coco C, et al. Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients. J Exp Clin Cancer Res. 2012;31:71.PubMedCentralPubMedCrossRef
5.
go back to reference Zhang W, et al. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res. 2008;68(8):2764–72.PubMedCentralPubMedCrossRef Zhang W, et al. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res. 2008;68(8):2764–72.PubMedCentralPubMedCrossRef
8.
go back to reference Cao JM, et al. High mobility group B proteins regulate mesoderm formation and dorsoventral patterning during zebrafish and Xenopus early development. Mech Dev. 2012;129(9–12):263–74.PubMedCrossRef Cao JM, et al. High mobility group B proteins regulate mesoderm formation and dorsoventral patterning during zebrafish and Xenopus early development. Mech Dev. 2012;129(9–12):263–74.PubMedCrossRef
9.
go back to reference Marchetti B, et al. Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson’s disease: the Wnt/beta-catenin signaling cascade as the common final pathway for neuroprotection and self-repair. Eur J Neurosci. 2013;37(10):1550–63.PubMedCentralPubMedCrossRef Marchetti B, et al. Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson’s disease: the Wnt/beta-catenin signaling cascade as the common final pathway for neuroprotection and self-repair. Eur J Neurosci. 2013;37(10):1550–63.PubMedCentralPubMedCrossRef
10.
go back to reference Hu S, et al. Sox31 is involved in central nervous system anteroposterior regionalization through regulating the organizer activity in zebrafish. Acta Biochim Biophys Sin (Shanghai). 2011;43(5):387–99.CrossRef Hu S, et al. Sox31 is involved in central nervous system anteroposterior regionalization through regulating the organizer activity in zebrafish. Acta Biochim Biophys Sin (Shanghai). 2011;43(5):387–99.CrossRef
11.
go back to reference Aksoy I, et al. Sox transcription factors require selective interactions with Oct4 and specific transactivation functions to mediate reprogramming. Stem Cells. 2013;31(12):2632–46. Aksoy I, et al. Sox transcription factors require selective interactions with Oct4 and specific transactivation functions to mediate reprogramming. Stem Cells. 2013;31(12):2632–46.
12.
go back to reference Jiang T, et al. The SOX gene family: function and regulation in testis determination and male fertility maintenance. Mol Biol Rep. 2013;40(3):2187–94.PubMedCrossRef Jiang T, et al. The SOX gene family: function and regulation in testis determination and male fertility maintenance. Mol Biol Rep. 2013;40(3):2187–94.PubMedCrossRef
13.
go back to reference Goding CR. Melanocyte development and malignant melanoma. Forum (Genova). 2000;10(3):176–87. Goding CR. Melanocyte development and malignant melanoma. Forum (Genova). 2000;10(3):176–87.
14.
go back to reference Soullier S, et al. Diversification pattern of the HMG and SOX family members during evolution. J Mol Evol. 1999;48(5):517–27.PubMedCrossRef Soullier S, et al. Diversification pattern of the HMG and SOX family members during evolution. J Mol Evol. 1999;48(5):517–27.PubMedCrossRef
15.
go back to reference Argenton F, et al. Ectopic expression and knockdown of a zebrafish sox21 reveal its role as a transcriptional repressor in early development. Mech Dev. 2004;121(2):131–42.PubMedCrossRef Argenton F, et al. Ectopic expression and knockdown of a zebrafish sox21 reveal its role as a transcriptional repressor in early development. Mech Dev. 2004;121(2):131–42.PubMedCrossRef
16.
go back to reference Juarez M, et al. Characterization of the trunk neural crest in the bamboo shark, Chiloscyllium punctatum. J Comp Neurol. 2013;521(14):3303–20.PubMedCrossRef Juarez M, et al. Characterization of the trunk neural crest in the bamboo shark, Chiloscyllium punctatum. J Comp Neurol. 2013;521(14):3303–20.PubMedCrossRef
17.
go back to reference Lakiza O, et al. SoxE gene duplication and development of the lamprey branchial skeleton: insights into development and evolution of the neural crest. Dev Biol. 2011;359(1):149–61.PubMedCrossRef Lakiza O, et al. SoxE gene duplication and development of the lamprey branchial skeleton: insights into development and evolution of the neural crest. Dev Biol. 2011;359(1):149–61.PubMedCrossRef
18.
19.
go back to reference Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8(5):387–98.PubMedCrossRef Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8(5):387–98.PubMedCrossRef
20.
go back to reference Liu Q, et al. Homologues of sox8 and sox10 in the orange-spotted grouper Epinephelus coioides: sequences, expression patterns, and their effects on cyp19a1a promoter activities in vitro. Comp Biochem Physiol B: Biochem Mol Biol. 2012;163(1):86–95.CrossRef Liu Q, et al. Homologues of sox8 and sox10 in the orange-spotted grouper Epinephelus coioides: sequences, expression patterns, and their effects on cyp19a1a promoter activities in vitro. Comp Biochem Physiol B: Biochem Mol Biol. 2012;163(1):86–95.CrossRef
21.
go back to reference Baarsma HA, et al. Activation of WNT/beta-catenin signaling in pulmonary fibroblasts by TGF-beta(1) is increased in chronic obstructive pulmonary disease. PLoS ONE. 2011;6(9):e25450.PubMedCentralPubMedCrossRef Baarsma HA, et al. Activation of WNT/beta-catenin signaling in pulmonary fibroblasts by TGF-beta(1) is increased in chronic obstructive pulmonary disease. PLoS ONE. 2011;6(9):e25450.PubMedCentralPubMedCrossRef
22.
go back to reference Vijayakumar S, et al. High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/beta-catenin target gene, CDC25A. Cancer Cell. 2011;19(5):601–12.PubMedCentralPubMedCrossRef Vijayakumar S, et al. High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/beta-catenin target gene, CDC25A. Cancer Cell. 2011;19(5):601–12.PubMedCentralPubMedCrossRef
23.
go back to reference Kormish JD, Sinner D, Zorn AM. Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev Dyn. 2010;239(1):56–68.PubMedCentralPubMed Kormish JD, Sinner D, Zorn AM. Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev Dyn. 2010;239(1):56–68.PubMedCentralPubMed
24.
go back to reference Korbut E, Ptak-Belowska A, Brzozowski T. Mechanisms promoting physiological cells progression into tumorigenesis. J Physiol Pharmacol. 2012;63(6):565–70.PubMed Korbut E, Ptak-Belowska A, Brzozowski T. Mechanisms promoting physiological cells progression into tumorigenesis. J Physiol Pharmacol. 2012;63(6):565–70.PubMed
25.
go back to reference Baylin SB, Ohm JE. Epigenetic gene silencing in cancer—a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006;6(2):107–16.PubMedCrossRef Baylin SB, Ohm JE. Epigenetic gene silencing in cancer—a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006;6(2):107–16.PubMedCrossRef
26.
go back to reference L’Episcopo F, et al. Reactive astrocytes and Wnt/beta-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. Neurobiol Dis. 2011;41(2):508–27.PubMedCentralPubMedCrossRef L’Episcopo F, et al. Reactive astrocytes and Wnt/beta-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. Neurobiol Dis. 2011;41(2):508–27.PubMedCentralPubMedCrossRef
27.
go back to reference Bafico A, et al. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 2004;6(5):497–506.PubMedCrossRef Bafico A, et al. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 2004;6(5):497–506.PubMedCrossRef
Metadata
Title
Oncogenicity of the transcription factor SOX8 in hepatocellular carcinoma
Authors
Siquan Zhang
Cong Zhu
Limin Zhu
Huafeng Liu
Shourong Liu
Nianbo Zhao
Jing Wu
Xiaoxiao Huang
Yujuan Zhang
Jie Jin
Ting Ji
Xianfeng Ding
Publication date
01-04-2014
Publisher
Springer US
Published in
Medical Oncology / Issue 4/2014
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0918-3

Other articles of this Issue 4/2014

Medical Oncology 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.